Fenwick Represents Kinnevik AB in Leading Cityblock Health’s $53.5 Million Series B+ Funding Round

Fenwick represented Kinnevik AB in leading Cityblock Health’s $53.5 million Series B+ round of funding. AIMS Imprint of Goldman Sachs Asset Management and Alphabet also participated in the round, and existing major investors, Maverick Ventures, Redpoint Ventures, Town Hall Ventures, Thrive Capital, Emblem Health, 8VC and Echo Health Ventures joined the round as well.

Cityblock partners with health plans to reach people in neighborhoods that face high poverty rates and accompanying social challenges. Kinnevik is an industry-focused investment company that partners with founders and management teams to build businesses that use disruptive technology to address material, everyday consumer needs. More information about the financing can be obtained from Cityblock’s announcement.

The Fenwick transaction team included corporate partner Ian Goldstein and associates Eugene Karlik and Jennifer Wu.